Joseph P. Neglia, M.D., M.P.H.

Professor, Department of Pediatrics
Section Chief, Pediatric Hematology/Oncology
Albert D. and Eva J. Corniea Chair
University of Minnesota School of Medicine
Mayo Mail Code 484
420 Delaware St. SE
Minneapolis, MN 55455
Phone: (612) 626-2778
Fax: (612) 626-2815
jneglia@umn.edu
Preferred method of contact:  Phone or Email

Dr. Joseph Neglia is currently a Professor in the Division of Pediatric Hematology/Oncology/Blood and Marrow Transplantation at the University of Minnesota in Minneapolis. He has been at the University of Minnesota since 1984 when he came to pursue a fellowship in Pediatric Hematology/Oncology and Blood and Marrow Transplantation.

Dr. Neglia received his M.D. degree in 1981 from Loma Linda University School of Medicine and was a pediatric intern, resident and chief resident at the Baylor College of Medicine in Houston, Texas. During his fellowship at the University of Minnesota, Dr. Neglia received a Master's degree in Public Health in Epidemiology. Following his fellowship, he was an Instructor in the Department of Pediatrics (1987), promoted to Assistant Professor in 1988, Associate Professor in 1992 and Full Professor in 2002. He has a joint appointment in the Department of Epidemiology in the School of Public Health.

Dr. Neglia's area of research involves the long-term effects of cancer therapy in cancer survivors and the occurrence of second malignancies following childhood cancer. He is nationally and internationally recognized for his contributions to the field of childhood cancer long-term effects. He currently is Principal Investigator at the University of Minnesota Cancer Center for the Children's Oncology Group (COG) and the vice-chair of the Voting Body of the COG. Dr. Neglia is currently the principal investigator of an American Cancer Society Grant investigation neuro-behavioral outcomes of children recently treated for leukemia.

Dr. Neglia has been involved in numerous service activities both within and outside of the University of Minnesota. He is an active member of the Children's Oncology Group, the American Society of Pediatric Hematology/Oncology, and the University of Minnesota Cancer Center. He regularly reviews manuscripts for numerous journals including the New England Journal of Medicine, the Journal of the National Cancer Institute, and Cancer among others. At the University level he has been elected as an alternate member of the University Senate, developed and directed the original Cancer Center Database.

Honors and Awards

• 1981 Alpha Omega Alpha
• 1981 Vice-President, Loma Linda University School of Medicine, Class of 1981
• 1983 Chief Pediatric Resident, Jefferson Davis County Hospital, Houston, TX
• 1984-85 Clinical Fellow, American Cancer Society
• 1987 American Association for Cancer Research - Upjohn Travel Award
• 1988 Pi Chapter, Delta Omega Public Health Honor Society

1. Long-term effects of cancer therapy.
2. Occurrence of second malignancies following childhood cancer.

Selected Recent Publications

Bassal M, Mertens AC, Taylor L, Neglia JP, Greffe BS, Hammond S, Ronckers CM,  Friedman DL, Stovall M, Yasui YY, Robison LL, Meadows AT, Kadan-Lottick NS: The Risk of Selected Subsequent Carcinomas in Survivors of Childhood Cancer:  A Report From the Childhood Cancer Survivor Study.  Journal of Clinical Oncology 24: 476-483, 2006. 

Fraser CJ, Hirsch BA, Dayton V, Creer MH, Neglia JP, Wagner, JE, Baker KS.  First report of donor cell-derived acute leukemia as a complication of umbilical cord Blood transplantation.  Blood, 106(13):4377-4380, 2005. 

Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, Meadows AT,

Hutchinson R, Dreyer ZE, Robison LL, Mertens AC. Nonmelanoma skin cancer in Survivors of childhood and adolescent cancer:  A report from the Childhood Cancer Survivor Study.  Journal of Clinical Oncology June 1,23(16):3733-41, 2005. 

Patton T, Olshan AF, Neglia JP, Castleberry RP:  Parental exposure to medical radiation and neuroblastoma in offspring.  Pediatric and Perinatal Epidemiology, 18:178-185, 2004. 

Tolar J, Tope WD, Neglia JP:  Leukotriene-Receptor Inhibition for the Treatment of Systemic Mastocytosis.  New England Journal of Medicine, 7:735-736, 2004. 

Yasui Y, Liu Y, Neglia J, Friedman, D, Bhatia S, Meadows A, Diller LR, Mertens A,  Whitten J, Robison LL:  A methodological issue in the analysis of secondary primary cancer incidence in long-term survivors of childhood cancers.  American Journal Epidemiology, 158(11):1108-1113, 2003. 

Packer RJ, Gurney JG, Punyko JA, Donaldson SS, Inskip PD, Stovall M, Yasui Y,  Mertens AC, Sklar CA, Nicholson HS, Zeltzer LK, Neglia JP, Robison LL:  Long-term  Neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: Childhood Cancer Survivor Study.  Journal of Clinical Oncology 21:3255-3261, 2003. 

Tolar J, Neglia JP.  Transplacental and other routes of cancer transmission between individuals:  A review of the literature.   Journal of Pediatric Hematology/Oncology 25:430-434, 2003. 

Nagarajan R, Neglia JP, Clohisy DR and Robison LL.  Limb Salvage and Amputation in Survivors of Pediatric Lower-Extremity Bone Tumors:  What are the Long-Term Implications?  Journal of Clinical Oncology 20:4493-4501, 2002. 

Tolar J, Coad JE, and Neglia J:  Transplacental Transfer of Small Cell  Carcinoma of the Lung.   New England Journal of Medicine, 1501-1502, 2002. 

Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stoval M, Donaldson SS, Meadows AT, Robison, LL.  Second Malignant Neoplasms in Five-Year Survivors of Childhood Cancer:  A Report from the Childhood Cancer Survivor Study. Journal of the National Cancer Institute. 93(8) 618-629, 2001. 

Nagarajan R, Neglia J, Ramsay N, and Baker KS:  Successful Treatment of Refractory   Langerhan Cell Histiocytosis with Unrelated Cord Blood Transplant.   Journal of Pediatric Hematology/Oncology 23(9) 629-632, 2001. 

Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME, Ruccione K, Smithson WA and Robison LL.  Late Mortality Experience in Five-Year Survivors of Childhood and Adolescent Cancer:  The Childhood Cancer Survivor Study.   Journal of Clinical Oncology. 19:3163-3172, 2001.